Australian University Rankings Guide

Journal of Biochemical and Molecular Toxicology (ERA Journal)

Journal of Biochemical and Molecular Toxicology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Journal of Biochemical and Molecular Toxicology issns are issn1: 1095-6670 issn2: 1099-0461.

The field covered by Journal of Biochemical and Molecular Toxicology as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- Anti-Cancer Drugs: international journal on anti-cancer agents
- BJPS: Brazilian Journal of Pharmaceutical Sciences
- BMC Pharmacology and Toxicology
- Clinical Drug Investigation
- Current Cancer Therapy Reviews
- Drug Development and Industrial Pharmacy
- Drugs - Real World Outcomes
- Expert Opinion on Emerging Drugs
- Expert Review of Pharmacoeconomics and Outcomes Research: informing decision-making in the delivery of cost-effective healthcare
- Folia Pharmacologica Japonica (Kyoto 1944)
- Geneesmiddelenbulletin
- International Journal of Clinical Pharmacology and Therapeutics
- Journal of Pharmacology and Pharmacotherapeutics
- Methods in Molecular Medicine
- Pharmactuel: la revue de la pratique pharmaceutique en etablissement de sante au Quebec


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4